Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870101 · ClinicalTrials.gov registry record · NA
Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT
A NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 2,767
- Enrollment target
- 9
- Study locations
NCT02870101 is a NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection that has completed, run by Duke University. The registered enrollment target is 2,767 participants, above the 631-participant average among 10 other Sexually Transmitted Infections trials with a reported enrollment target (339% higher). The trial reports 9 study locations across 7 states.
The verdict
NCT02870101, a NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,767 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Nucleic acid amplification test 1 for NG and CT
- DIAGNOSTIC_TEST Nucleic acid amplification test 2 for NG and CT
- DIAGNOSTIC_TEST Nucleic acid amplification test 3 for NG and CT
Study Locations (9)
California
- AIDS Health Foundation - Hollywood - Hollywood
- Los Angeles LGBT Clinic - Los Angeles
Florida
- AIDS Healthcare Foundation - Miami - Miami
- University of Miami - Miami
Colorado
- Denver Health and Hospital Authority - Denver
Louisiana
- Louisiana State University - New Orleans
Michigan
- Wayne State University - Detroit
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- Central Texas Clinical Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,767 participants |
| Start Date | 2017-04-10 |
| Est. Completion | 2018-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02870101
The ClinicalTrials.gov registry entry for NCT02870101 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,767 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 631-participant average among 10 other Sexually Transmitted Infections trials with a reported enrollment target (339% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sexually Transmitted Infections appearing as the primary indexed condition, and to 3 interventions - of which Nucleic acid amplification test 1 for NG and CT is the first listed.
NCT02870101 reports 9 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Colorado.
Frequently Asked Questions
What is clinical trial NCT02870101 about?
NCT02870101 is a clinical study titled "Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT". The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.
What is the current status of trial NCT02870101?
This trial is currently completed. It is a NA study. The enrollment target is 2,767 participants. The study started on 2017-04-10. Estimated completion is 2018-03-12.
What conditions does trial NCT02870101 study?
This clinical trial studies the following conditions: Sexually Transmitted Infections, Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection.
What interventions are being tested in trial NCT02870101?
The interventions under investigation include: Nucleic acid amplification test 1 for NG and CT (DIAGNOSTIC_TEST), Nucleic acid amplification test 2 for NG and CT (DIAGNOSTIC_TEST), Nucleic acid amplification test 3 for NG and CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02870101?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02870101 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gathering Online for Dialogue and Discussion to Enhance Social Support
RECRUITING · NA
-
Evaluation of the SafeSpace App Intervention
RECRUITING · NA
-
Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
HIV Prevention Program for African American Teen Males
COMPLETED · NA
-
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
COMPLETED · NA
Explore more on PlainTrial
Sexually Transmitted Infections
All registered trials for this condition
Neisseria Gonorrhoeae Infection
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.